Abstract:Abstract Background N6-methyladenosine (m6A) RNA methylation plays a critical role in key genetic events for various cancers; yet, how m6A functions within the tumor microenvironment (TME) remains to be elucidated. Methods A total of 65,362 single cells from single-cell RNA-seq data derived from 33 CRC tumor samples were analyzed by nonnegative matrix factorization (NMF) for 23 m6A RNA methylation regulators. CRC and Immunotherapy cohorts from public repository were used to determine the prognosis and immune response of TME clusters. Results The fibroblasts, macrophages, T and B cells were respectively grouped into 4 to 5 subclusters and then classified according to various biological processes and different marker genes. Furthermore, it revealed that the m6A RNA methylation regulators might be significantly related to the clinical and biological features of CRC, as well as the pseudotime trajectories of main TME cell types. Bulk-seq analysis suggested that these m6A-mediated TME cell subclusters had significant prognostic value for CRC patients and distinguished immune response for patients who underwent ICB therapy, especially for the CAFs and macrophages. Notably, CellChat analysis revealed that RNA m6A methylation-associated cell subtypes of TME cells manifested diverse and extensive interaction with tumor epithelial cells. Further analysis showed that ligand-receptor pairs, including MIF − (CD74 + CXCR4), MIF − (CD74 + CD44), MDK–NCL and LGALS9 − CD45, etc. mediated the communication between m6A associated subtypes of TME cells and tumor epithelial cells. Conclusions Taken together, our study firstly revealed the m6A methylation mediated intercellular communication of the tumor microenvironment in the regulation of tumor growth and antitumor immunomodulatory processes.

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

Interaction Between N6-methyladenosine Modification and the Tumor Microenvironment in Colorectal Cancer

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Single-cell N6-methyladenosine Regulator Patterns Guide Intercellular Communication of Tumor Microenvironment That Contribute to Colorectal Cancer Progression and Immunotherapy

N6-methyladenosine-dependent signaling in colorectal cancer: functions and clinical potential

The crucial roles of N 6 -methyladenosine (m 6 A) modification in the carcinogenesis and progression of colorectal cancer

The Crucial Roles of N6-methyladenosine (m6a) Modification in the Carcinogenesis and Progression of Colorectal Cancer

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer

N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

The Implications of N6-methyladenosine (m6a) Modification in Esophageal Carcinoma

Roles and implications of mRNA N 6 ‐methyladenosine in cancer

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

Roles and Implications of Mrna N6 -Methyladenosine in Cancer.

RNA m<SUP>6</SUP>A methylation in cancer

<scp>RNA m<sup>6</sup>A</scp> methylation in cancer

N-6-Methyladenosine: A Novel RNA Imprint in Human Cancer

RNA M6a Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.

Comprehensive Analysis of N6-methylandenosine Regulators and M6a-Related RNAs As Prognosis Factors in Colorectal Cancer

RNA N6-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications